MRC Technology, Genentech Sign Exclusive License Agreement For Small Molecule Drug Discovery Programme
As per the terms of the agreement, Genentech is expected to provide MRC Technology an upfront payment and also provide clinical development milestone payments and royalties on sales.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.